IRADIMED CORPORATION Statistics
Total Valuation
IRMD has a market cap or net worth of $665.80 million. The enterprise value is $617.63 million.
| Market Cap | 665.80M |
| Enterprise Value | 617.63M |
Important Dates
The next confirmed earnings date is Thursday, October 31, 2024, before market open.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | Aug 20, 2024 |
Share Statistics
IRMD has 12.67 million shares outstanding. The number of shares has increased by 0.61% in one year.
| Shares Outstanding | 12.67M |
| Shares Change (YoY) | +0.61% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 37.03% |
| Owned by Institutions (%) | 48.84% |
| Float | 7.10M |
Valuation Ratios
The trailing PE ratio is 36.00 and the forward PE ratio is 35.27.
| PE Ratio | 36.00 |
| Forward PE | 35.27 |
| PS Ratio | 9.56 |
| Forward PS | 17.32 |
| PB Ratio | 8.36 |
| P/FCF Ratio | 49.02 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.75, with an EV/FCF ratio of 45.47.
| EV / Earnings | 33.13 |
| EV / Sales | 8.89 |
| EV / EBITDA | 27.75 |
| EV / EBIT | 28.81 |
| EV / FCF | 45.47 |
Financial Position
The company has a current ratio of 9.87, with a Debt / Equity ratio of 0.00.
| Current Ratio | 9.87 |
| Quick Ratio | 8.11 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.03 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 25.08% and return on invested capital (ROIC) is 17.71%.
| Return on Equity (ROE) | 25.08% |
| Return on Assets (ROA) | 15.64% |
| Return on Capital (ROIC) | 17.71% |
| Revenue Per Employee | $469,485 |
| Profits Per Employee | $125,977 |
| Employee Count | 148 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.55 |
Taxes
In the past 12 months, IRMD has paid $4.96 million in taxes.
| Income Tax | 4.96M |
| Effective Tax Rate | 21.01% |
Stock Price Statistics
The stock price has increased by +27.49% in the last 52 weeks. The beta is 0.81, so IRMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +27.49% |
| 50-Day Moving Average | 48.62 |
| 200-Day Moving Average | 44.88 |
| Relative Strength Index (RSI) | 67.30 |
| Average Volume (20 Days) | 25,254 |
Short Selling Information
The latest short interest is 77,732, so 0.61% of the outstanding shares have been sold short.
| Short Interest | 77,732 |
| Short Previous Month | 74,407 |
| Short % of Shares Out | 0.61% |
| Short % of Float | 1.09% |
| Short Ratio (days to cover) | 1.72 |
Income Statement
In the last 12 months, IRMD had revenue of $69.48 million and earned $18.64 million in profits. Earnings per share was $1.46.
| Revenue | 69.48M |
| Gross Profit | 53.65M |
| Operating Income | 21.44M |
| Pretax Income | 23.60M |
| Net Income | 18.64M |
| EBITDA | 22.26M |
| EBIT | 21.44M |
| Earnings Per Share (EPS) | $1.46 |
Balance Sheet
The company has $48.54 million in cash and $371,849 in debt, giving a net cash position of $48.16 million or $3.80 per share.
| Cash & Cash Equivalents | 48.54M |
| Total Debt | 371,849 |
| Net Cash | 48.16M |
| Net Cash Per Share | $3.80 |
| Equity (Book Value) | 79.67M |
| Book Value Per Share | 6.29 |
| Working Capital | 66.12M |
Cash Flow
In the last 12 months, operating cash flow was $15.83 million and capital expenditures -$2.24 million, giving a free cash flow of $13.58 million.
| Operating Cash Flow | 15.83M |
| Capital Expenditures | -2.24M |
| Free Cash Flow | 13.58M |
| FCF Per Share | $1.07 |
Margins
Gross margin is 77.21%, with operating and profit margins of 30.86% and 26.83%.
| Gross Margin | 77.21% |
| Operating Margin | 30.86% |
| Pretax Margin | 33.97% |
| Profit Margin | 26.83% |
| EBITDA Margin | 32.04% |
| EBIT Margin | 30.86% |
| FCF Margin | 18.72% |
Dividends & Yields
This stock pays an annual dividend of $0.60, which amounts to a dividend yield of 1.14%.
| Dividend Per Share | $0.60 |
| Dividend Yield | 1.14% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 41.10% |
| Buyback Yield | -0.61% |
| Shareholder Yield | 0.53% |
| Earnings Yield | 2.80% |
| FCF Yield | 2.04% |
Analyst Forecast
The average price target for IRMD is $60.00, which is 14.18% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $60.00 |
| Price Target Difference | 14.18% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRMD has an Altman Z-Score of 35.5 and a Piotroski F-Score of 6.
| Altman Z-Score | 35.5 |
| Piotroski F-Score | 6 |